Literature DB >> 25213274

Intrahepatic antiviral quantification in a patient undergoing orthotopic cadaveric liver transplantation.

Kaitlyn J Moorehead1, James R Burton2, Gregory T Everson2, Jia-Hua Zheng1, Becky Jo Kerr1, Lane R Bushman1, Meng Wang1, Cynthia Ju1, Trevor Nydam3, Jennifer J Kiser4.   

Abstract

Entities:  

Keywords:  intrahepatic; liver sampling; nucleosides; pharmacokinetics; tenofovir diphosphate

Mesh：

Substances：

Year:  2014        PMID： 25213274      PMCID： PMC4267500          DOI： 10.1093/jac/dku334

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  9 in total

1.  Effect of antacids on the pharmacokinetics of raltegravir in human immunodeficiency virus-seronegative volunteers.

Authors:  Jennifer J Kiser; J Brock Bumpass; Amie L Meditz; Peter L Anderson; Lane Bushman; Michelle Ray; Julie A Predhomme; Joseph Rower; Sam Mawhinney; Richard Brundage
Journal:  Antimicrob Agents Chemother       Date:  2010-10-04       Impact factor: 5.191

2.  Atazanavir and atazanavir/ritonavir pharmacokinetics in HIV-infected infants, children, and adolescents.

Authors:  Jennifer J Kiser; Richard M Rutstein; Pearl Samson; Bobbie Graham; Grace Aldrovandi; Lynne M Mofenson; Elizabeth Smith; Steven Schnittman; Terry Fenton; Richard C Brundage; Courtney V Fletcher
Journal:  AIDS       Date:  2011-07-31       Impact factor: 4.177

3.  Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.

Authors:  Lane R Bushman; Jennifer J Kiser; Joseph E Rower; Brandon Klein; Jia-Hua Zheng; Michelle L Ray; Peter L Anderson
Journal:  J Pharm Biomed Anal       Date:  2011-06-06       Impact factor: 3.935

4.  Telaprevir-based treatment effects on hepatitis C virus in liver and blood.

Authors:  Andrew H Talal; Rositsa B Dimova; Eileen Z Zhang; Min Jiang; Marina S Penney; James C Sullivan; Martyn C Botfield; Ananthsrinivas Chakilam; Rishikesh Sawant; Christine M Cervini; Marija Zeremski; Ira M Jacobson; Ann D Kwong
Journal:  Hepatology       Date:  2014-07-31       Impact factor: 17.425

5.  The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.

Authors:  Tom Delahunty; Lane Bushman; Brian Robbins; Courtney V Fletcher
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-05-21       Impact factor: 3.205

Review 6.  Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.

Authors:  Roger K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

7.  Gene expression analysis in serial liver fine needle aspirates.

Authors:  S Lejnine; M J Marton; I-M Wang; B J Howell; A L Webber; J W Maxwell; N Shire; V Malkov; J Lunceford; M Zeremski; A Sun; M Ruddy; A H Talal
Journal:  J Viral Hepat       Date:  2014-01-29       Impact factor: 3.728

8.  Uniformity of liver density and nonheme (storage) iron distribution.

Authors:  B A Overmoyer; C E McLaren; G M Brittenham
Journal:  Arch Pathol Lab Med       Date:  1987-06       Impact factor: 5.534

Review 9.  Perspectives and challenges of interferon-free therapy for chronic hepatitis C.

Authors:  Christian M Lange; Stefan Zeuzem
Journal:  J Hepatol       Date:  2012-10-24       Impact factor: 25.083
  9 in total
  1 in total

1.  Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques.

Authors:  Charles S Venuto; Marianthi Markatou; Yvonne Woolwine-Cunningham; Rosemary Furlage; Andrew J Ocque; Robin DiFrancesco; Emily O Dumas; Paul K Wallace; Gene D Morse; Andrew H Talal
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.